From the data, what drugs to sell are the most profitable

Regardless of the main business or profit, the chemical preparations manufacturing industry is the largest proportion of the pharmaceutical industry. Today (July 12), the Ministry of Industry and Information Technology released “Completion of Major Economic Indicators for the Pharmaceutical Industry in 2015” and “Completion of Major Economic Indicators for the Pharmaceutical Industry in January-April 2016.”

According to statistics and relevant statistical information, the major economic indicators of the pharmaceutical industry in 2015 and 2016 were as follows:

In 2015, the added value of pharmaceutical industries above designated size grew by 9.8% year-on-year, and the growth rate was down 2.7 percentage points from the previous year, which was 3.7 percentage points higher than the overall industrial growth rate. The added value of the pharmaceutical industry accounted for 3.0% of the total industrial added value, which represented an increase of about 0.2 percentage point from the previous year, reflecting the further increase in the contribution of the pharmaceutical industry to overall industrial growth.

From January to April, the added value of pharmaceutical industries above designated size increased by 9.6% year-on-year, and the growth rate was 1.1 percentage points lower than the same period of last year, which was higher than the overall industrial growth rate by 3.8 percentage points. The added value of the pharmaceutical industry in the overall industry accounted for 3.3.

First, the main business income

From the perspective of the main business income, according to the sub-industry rankings, they are chemical preparations, Chinese patent medicine manufacturing, chemical raw material pharmaceutical manufacturing, bio-medicine manufacturing, medical equipment and apparatus manufacturing, sanitary materials and medical supplies manufacturing, and Chinese herbal medicines. Processing, pharmaceutical machinery manufacturing.

In 2015, the enterprises above designated size in the pharmaceutical industry realized main business income of 2,688.591 billion yuan, an increase of 9.02% year-on-year, 8.22 percentage points higher than the national industrial growth rate, but a decrease of 4.42 percentage points from the previous year. In various sub-sectors, the growth rate of proprietary Chinese medicines and pharmaceutical equipment is lower than the industry average.

From January to April, the enterprises above designated size in the pharmaceutical industry achieved a total revenue of RMB 868.923 billion, a year-on-year increase of 10.4%, which was higher than the overall national industrial growth of 8.1 percentage points and 0.89 percentage point higher than the same period of last year. Among all sub-sectors, medical equipment, equipment, and Chinese Herbal Pieces are the fastest-growing main business revenues.

Second, profits

Judging from the ranking of total profits, chemical drugs still hold the top spot, followed by Chinese patent medicine, biological medicine, raw material medicine, medical equipment and apparatus manufacturing, sanitary materials and medical supplies manufacturing, Chinese herbal medicine processing, and pharmaceutical machinery manufacturing.

In 2015, the total profit of pharmaceutical enterprises above designated size was 276.823 billion yuan, a year-on-year increase of 12.22%, which was higher than the national industrial growth rate of 14.52 percentage points, a decrease of 0.93 percentage points from the previous year. The annual profit growth rate was higher than the growth rate of main business income, indicating that the profitability of the pharmaceutical industry has improved.

From January to April, the total profit of pharmaceutical enterprises above designated size was 57.678 billion yuan, a year-on-year increase of 16.3%, which was higher than the overall national industrial growth rate of 9.8 percentage points, and an increase of 4.66 percentage points from the same period of last year. Among the sub-industries, the fastest-growing profits were in chemical raw material medicine, medical equipment and equipment, but at the same time, the profits of pharmaceutical equipment showed negative growth.

Third, the amount of exports

In 2015, the enterprises above designated size in the pharmaceutical industry achieved an export delivery value of 179.85 billion yuan, a year-on-year increase of 3.6%, and the growth rate was down 6.1 percentage points from the previous year. According to the import and export data of the customs, the export volume of pharmaceutical products in 2015 was US$56.44 billion, which was a year-on-year increase of 2.7%, and the growth rate was down by 4.7 percentage points from the previous year. The export structure has improved, and the proportion of exports of chemical preparations and medical instruments has increased.

From January to April, the enterprises above designated size in the pharmaceutical industry realized an export delivery value of 58.556 billion yuan, an increase of 6.48% year-on-year, an increase of 1.96 percentage points from the same period of last year.

IV. Investment in Fixed Assets

In 2015, the pharmaceutical manufacturing industry completed 581.2 billion yuan in fixed asset investment, an increase of 11.9% year-on-year, a deceleration of 3.2 percentage points from the previous year, which was 4.2 percentage points higher than the overall national industrial growth rate. While maintaining a relatively rapid growth, it is reflected that the technological transformation of enterprises focused on GMP upgrading and the construction of new plants since the 12th Five-Year Plan period is gradually decreasing.